News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitcoin adoption ‘booming’ while price chops: Which metrics matter most?2Bitget UEX Daily ｜US-Iran Conflict Escalates, Shaking Markets; Oil Prices, Gold and Silver Surge, Stock Index Futures Fall; Tech Stocks Show Mixed Performance (March 02, 2026)3SEC approval sought for JitoSOL Solana-based liquid staking token ETF
Can US lawmakers pass crypto market structure before the midterms?
Cointelegraph·2026/03/02 20:57
Opendoor's Technical Breakdown: A 7% Drop Tests Key Support
101 finance·2026/03/02 20:42
A Review of Q4 Earnings for HR Software Stocks: Comparing Paycom (NYSE:PAYC) with Its Competitors
101 finance·2026/03/02 20:39
Wedbush's Sector Split: The Expectation Arbitrage in AppLovin, Unity, and Playtika
101 finance·2026/03/02 20:33
Q4 Financial Results: Comparing Baxter (NYSE:BAX) With Other Diversified Medical Devices & Supplies Stocks
101 finance·2026/03/02 20:30
Netflix chief: I feel uneasy about the result and our final position
101 finance·2026/03/02 20:24
Q4 Earnings Overview: Comparing Kyndryl (NYSE:KD) With Other IT Services & Consulting Companies
101 finance·2026/03/02 20:21
CHAT vs. SOXX: Evaluating the AI ETF Opportunity Following Recent Gains
101 finance·2026/03/02 20:15
Flash
20:53
Chicago wheat futures fell about 2.6%, soybean meal dropped 2.5%, and soybean oil rose over 1.3%.CBOT corn futures fell 0.72%, quoted at $4.4525 per bushel. CBOT wheat futures dropped 2.58%, quoted at $5.7625 per bushel, remaining roughly stable around $5.90 before 21:44 (UTC+8), but accelerated downward after the US stock market opened. CBOT soybean futures fell 0.77%, quoted at $11.6175 per bushel; soybean meal futures dropped 2.50%, while soybean oil futures rose 1.34%.
20:49
Eli Lilly's Chief Financial Officer recently stated that its oral GLP-1 receptor agonist Orforglipron could enter the US market as early as the second quarter of this year, following expected regulatory approval in April.This timeline has been confirmed by investment bank TD Cowen. If this pill formulation successfully enters the market, it will break through the current limitation of GLP-1 drugs requiring injection administration, providing a more convenient treatment option for diabetes and obesity patients. Market analysis points out that the oral formulation is expected to significantly improve drug accessibility and may further expand Eli Lilly's market advantage in the field of metabolic disease treatment.
20:49
Elliott Investment Management pointed out that Norwegian Cruise Line (NCLH) released a disappointing financial outlook for 2026, which shows a significant gap with the company's actual development potential.The institution believes that current forecasts do not fully reflect the growth potential and business value that Norwegian Cruise Line should have.
News